Regeneron profit beats estimates on Dupixent strength
Go back to Regeneron profit beats estimates on Dupixent strength| Regeneron (NASDAQ: REGN) | Delayed: 735.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $735.20 | 52 Week High | $592.36 | |||
| Open | $735.20 | 52 Week Low | $325.35 | |||
| Day High | $735.20 | P/E | 192.97 | |||
| Day Low | $735.20 | EPS | $3.81 | |||
| Volume | 178 | |||||

